Nature-Inspired Innovation in Cancer Resistance

Israeli biotech company caVos Biotherapeutics has developed a groundbreaking technology inspired by nature specifically, how certain animals have evolved remarkable traits such as cancer resistance and rapid healing. By leveraging comparative genomics, caVos Biotherapeutics analyzes genetic and protein-level differences between species to uncover the biological secrets behind these “super-traits.”

Using advanced algorithms, caVos Biotherapeutics identifies subtle yet powerful changes in proteins, such as tiny shifts in regions that have remained nearly unchanged throughout evolution. These changes are often the key to unlocking nature’s most resilient defense mechanisms.

By translating these insights into new, precise, and safe drugs, caVos Biotherapeutics harnesses what nature has proven effective over millennia. Since 2021, Israel’s Innovation Authority has supported caVos Biotherapeutics through strategic funding and risk-sharing, accelerating scientific validation and critical development milestones.

caVos Biotherapeutics Biotech proves that sometimes, the answers to our biggest challenges lie hidden in plain sight and waiting to be discovered by those who know where to look

This is nature decoded and reimagined as the next frontier in precision medicine.